Document is current
Any future updates will be listed below
-
Authors
Smith, Katherine E. R.
Ayers-Ringler, Jennifer R.
Orme, Jacob J.
Lucien, Fabrice
Kim, Yohan
Winters, Jeffrey L.
Mansfield, Aaron S.
- License Information
-
More Information
Article History
Received: 23 November 2024
Accepted: 8 April 2025
First Online: 16 April 2025
Declarations
:
: JO reports support and/or research and consulting support from the Prostate Cancer Foundation, NaNotics, Genentech, and Partner Therapeutics. FL reports receiving research support to institution from Nanotics LLC; serving as scientific consultant for Mursla Bio; receiving royalties from Early is Good. AM reports receiving support from Genentech and Janssen for manuscript publication; receiving research support to institution from Novartis and Verily; receiving honoraria to institution for participation on advisory boards for AbbVie, AstraZeneca, Bristol-Myers Squibb, Genentech, Janssen and Takeda Oncology; serving as steering committee member for Janssen and Johnson & Johnson Global Services; having speaking engagements from Chugai Pharmaceutical Co., Ltd. (Roche); serving as grant reviewer for Rising Tide; having expert think tank participation in TRIPTYCH Health Partners; serving as a moderator for Ideology Health LLC (formerly Nexus Health Media); having CME presentation for Intellisphere LLC (OncLive Summit Series) and Answers in CME; having presentation for Immunocore; serving on the advisory board for Sanofi Genzyme; receiving honoraria to self for CME presentation for Antoni van Leeuwenhoek Kanker Instituut and MJH Life Sciences (OncLive); having presented to the University of Miami International Mesothelioma Symposium; receiving travel support from Roche; serving as nonremunerated director of the Mesothelioma Applied Research Foundation and member of the Friends of Patan Hospital Board of Directors; and receiving study funding and article process charges from Bristol-Myers Squibb. He has been supported by a Mark Foundation ASPIRE Award, Thymic Carcinoma Center Research Award, Department of Defense Concept Award W81XWH-22-1-0021, NCI R21 (CA251923), NCI R33 (CA272271), and NCI U24 (CA283479). The remaining authors declare no competing interests.
: The TPE portion of this manuscript was part of a study approved by the Mayo Clinic Institutional Review Board (IRB# 19-008055). All patients (or legal guardians) provided informed consent to participate in this study and all experiments were performed within our institutional guidelines and regulations and in accordance with the Declaration of Helsinki.
